In epilepsy, mutations in the mTOR pathway may reset not only cellular excitability and seizures, but also dysregulate mitochondrial function and morphological sprouting, precluding perturbation-induced readjustment of the setpoint from transforming a highly synchronized and excited state back to the norm. The gene discussed is MTOR; the disease is epilepsy.